Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Harmer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2013
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancerLiam Welsh, Ceri Powell, Brenda Pratt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysisPrasad Dandekar, Clive Harmer, Yolanda Barbachano, et al.
World Journal of Surgical Oncology|April 5, 2008
Thyroid cancer causing obstruction of the great veins in the neckSteve L Hyer, Prasad Dandekar, Kate Newbold, et al.
Acta Oncologica (Stockholm, Sweden)|November 17, 2004
Medullary and non-medullary thyroid cancer in a familyAudrey Ardern-Jones, Roderick J Harvey, Philip Wilson, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
European Journal of Endocrinology|November 2, 2005
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportFurio Pacini, Martin Schlumberger, Clive Harmer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I studyTeresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2013
Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancerLiam Welsh, Ceri Powell, Brenda Pratt, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2009
Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysisPrasad Dandekar, Clive Harmer, Yolanda Barbachano, et al.
World Journal of Surgical Oncology|April 5, 2008
Thyroid cancer causing obstruction of the great veins in the neckSteve L Hyer, Prasad Dandekar, Kate Newbold, et al.
Acta Oncologica (Stockholm, Sweden)|November 17, 2004
Medullary and non-medullary thyroid cancer in a familyAudrey Ardern-Jones, Roderick J Harvey, Philip Wilson, et al.
Carcinogenesis|November 25, 2003
Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin geneAthena Matakidou, Nancy Hamel, Sanjay Popat, et al.
European Journal of Endocrinology|November 2, 2005
Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus reportFurio Pacini, Martin Schlumberger, Clive Harmer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2007
Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I studyTeresa Guerrero Urbano, Catharine H Clark, Vibeke N Hansen, et al.
The New England Journal of Medicine|May 4, 2012
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancerUjjal Mallick, Clive Harmer, Beng Yap, et al.
Pageof 2